Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Charles River Laboratories International Inc (NYSE:CRL)

80.35
Delayed Data
As of Jun 24
 -3.83 / -4.55%
Today’s Change
59.99
Today|||52-Week Range
87.95
-0.05%
Year-to-Date

Today’s Trading

Previous close84.18
Today’s open81.55
Day’s range80.14 - 82.07
Volume406,219
Average volume (3 months)432,885
Market cap$3.8B
Dividend yield--
Data as of 4:02pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+17.67%
Earnings growth (this year)+16.83%
Earnings growth (next 5 years)+13.01%
Revenue growth (last year)+5.06%
P/E ratio24.5
Price/Sales2.80
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+0.21+0.31%
PRXLPAREXEL Internationa...-1.20-1.98%
ALNYAlnylam Pharmaceutic...-2.64-4.64%
IONSIonis Pharmaceutical...-1.63-6.91%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$1.10
Annual revenue (last year)$1.4B
Annual profit (last year)$149.3M
Net profit margin11.02%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
James C. Foster
Chief Financial Officer &
Executive Vice President
David R. Smith
Corporate headquarters
Wilmington, Massachusetts

Forecasts

Partner Offers

Search for Jobs